This invention is an innovative breakthrough in cancer radiotherapy, offering a cutting-edge solution to address the challenges of radio-resistant and immunosuppressive tumors.
A team of Stanford researchers have identified a novel small molecule that could be used in vivo or ex vivo to enrich for submandibular salivary gland (SMG) stem cell (SC).